Then we orthotopically injected GL261 glioma cells and macrophages transfected with LV-shFTL into C57BL/6N mice and then conducted a PD1 mAb injection to assess the anti-tumor capability (Figure 8A). The gene discussed is PDCD1; the disease is central nervous system cancer.